Department of Medical Microbiology University of Ghana Medical School, Korle Bu, Ghana.
Department of Science Laboratory Technology Accra Technical University, Accra, Ghana.
Biomed Res Int. 2024 Aug 27;2024:8368996. doi: 10.1155/2024/8368996. eCollection 2024.
To describe the profile of , identify research gaps, and provide in-depth insights into various aspects related to the pathogen. Google Scholar, PubMed, and ScienceDirect were searched for all studies on the pneumococcus in Ghana that reported on specimen collected, population and sample size, carriage prevalence, incidence of pneumococcal diseases, age of the study population, types of test performed, serotypes identified, antimicrobial susceptibilities, or molecular analysis on the pneumococci for data extraction. Overall, a total of 7954 results were obtained from the three-database search, and of this, 24 articles were selected after screening. A total of 924 isolates were accounted for by serotyping/serogrouping. The prevalence of pneumococcal carriage in Ghana ranges from 11.0% to 51.4% in the population depending on the age (≤ 24-80 years), sickle cell disease (SCD), human immunodeficiency virus (HIV) status, or health of the study population, and penicillin (Pen)-nonsusceptible isolates ranged from 17% to 63%. The prevalence of pneumococci found as the etiologic agent of diseases among Ghanaians ranges from 3.4% for otitis media to 77.7% for meningitis. Overall, the 13-valent pneumococcal conjugate vaccine (PCV) (PCV-13) carriage serotypes accounted for 28.4% of the reported pneumococcal isolates. PCV-13 invasive serotypes accounted for 22.4% of the reported isolates. The non-PCV-13 carriage serotypes accounted for most (43.9%) of the reported isolates. In the pre-PCV-13 era, the nontypeable (NT) (5.5%) and other nonvaccine types (NVTs) (6.4%) were reported as being predominant. The non-PCV-13 serotypes accounted for 4.4% of the reported isolates in invasive pneumococcal disease (IPD) cases. Multidrug resistance (MDR) ranged from 7.8% to 100%. Predicting the invasiveness of pneumococci using molecular typing is the way to go in the future as this will provide answers to the extent to which capsular switching is contributing to the pneumococcal disease burden in Ghana almost a decade after introducing PCV-13. Continuous monitoring of antibiotic resistance patterns at both phenotypic and genotypic levels, along with serotyping and molecular typing, should be a standard practice in the surveillance of pneumococcal disease burden in Ghana.
描述 、识别研究空白,并深入了解与病原体相关的各个方面。在 Google Scholar、PubMed 和 ScienceDirect 上搜索了加纳所有关于肺炎球菌的研究,这些研究报告了采集的标本、人群和样本量、携带率、肺炎球菌疾病的发病率、研究人群的年龄、进行的测试类型、鉴定的血清型、抗生素敏感性或对肺炎球菌的分子分析,以进行数据提取。总体而言,从这三个数据库的搜索中获得了 7954 个结果,经过筛选后选择了 24 篇文章。通过血清分型/血清群分析共获得 924 株分离株。根据年龄(≤24-80 岁)、镰状细胞病(SCD)、人类免疫缺陷病毒(HIV)状态或研究人群的健康状况,加纳肺炎球菌携带率在 11.0%至 51.4%之间,青霉素(Pen)不敏感分离株的范围为 17%至 63%。在加纳人中,作为疾病病因的肺炎球菌的发现率从中耳炎的 3.4%到脑膜炎的 77.7%不等。总体而言,13 价肺炎球菌结合疫苗(PCV)(PCV-13)携带血清型占报告肺炎球菌分离株的 28.4%。PCV-13 侵袭性血清型占报告分离株的 22.4%。非 PCV-13 携带血清型占报告分离株的大多数(43.9%)。在 PCV-13 之前的时代,报告称无血清型(NT)(5.5%)和其他非疫苗型(NVT)(6.4%)为主要血清型。非 PCV-13 血清型占报告侵袭性肺炎球菌病(IPD)病例中分离株的 4.4%。多药耐药性(MDR)的范围为 7.8%至 100%。使用分子分型预测肺炎球菌的侵袭性是未来的发展方向,因为这将提供答案,说明在引入 PCV-13 近十年后,荚膜转换对加纳肺炎球菌疾病负担的影响程度。在加纳,应将连续监测表型和基因型、血清分型和分子分型的抗生素耐药模式作为监测肺炎球菌疾病负担的标准做法。